Clinical Trial Update: Hepatocellular Carcinoma Imaging Using PSMA PET/CT [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating PSMA PET/CT imaging for hepatocellular carcinoma; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Peter MacCallum Cancer Centre, Australia | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING